US BANCORP \DE\ - APPLIED MOLECULAR TRANS INC ownership

APPLIED MOLECULAR TRANS INC's ticker is AMTI and the CUSIP is 03824M109. A total of 44 filers reported holding APPLIED MOLECULAR TRANS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 2.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of APPLIED MOLECULAR TRANS INC
ValueSharesWeighting
Q1 2023$12
-25.0%
390.0%0.00%
Q4 2022$16390.0%0.00%
Q3 2022$0390.0%0.00%
Q2 2022$0390.0%0.00%
Q1 2022$0
-100.0%
39
-98.2%
0.00%
Q4 2021$30,000
+150.0%
2,149
+365.2%
0.00%
Q3 2021$12,000
+500.0%
462
+1084.6%
0.00%
Q2 2021$2,000390.00%
Other shareholders
APPLIED MOLECULAR TRANS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Founders Fund V Management, LLC 3,611,615$567,02470.62%
Founders Fund VI Management, LLC 826,607$129,7770.98%
EPIQ Capital Group, LLC 8,689,075$1,364,1850.71%
GEODE CAPITAL MANAGEMENT, LLC 139,808$21,9490.00%
OSAIC HOLDINGS, INC. 500$780.00%
STATE STREET CORP 55,055$8,6440.00%
NEW YORK STATE COMMON RETIREMENT FUND 650$00.00%
TWO SIGMA INVESTMENTS, LP 49,958$7,8430.00%
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 66,207$10,3950.00%
Qube Research & Technologies Ltd 2,104$3300.00%
View complete list of APPLIED MOLECULAR TRANS INC shareholders